en

PRODUCT DETAIL

Rapibloc 20 mg/2 ml koncentrát na injekčný roztok

Code 1310C
MA number 13/0445/16-S
Product Form: con inj 5x2 ml (amp.skl.)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 13 - ANTIARRYTHMICA
ATC:
C CARDIOVASCULAR SYSTEM
C07 BETA BLOCKING AGENTS
C07A BETA BLOCKING AGENTS
C07AB Beta blocking agents, selective
C07AB14 Landiolol
Shelf life: 18
Container: glass ampoule
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 29.09.2016
SPC: SPC_Rapibloc 20 mg/2 ml koncentrát na injekčný roztok_02_2022.pdf  
PIL: PIL_Rapibloc 20 mg/2 ml ml koncentrát na injekčný roztok_10_2021.pdf  
Safety feature Yes
Data update: 28.10.2021
eu-flag.png sk-flag.png